These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13747075)

  • 1. [Clinical experience with trypsin-heparin mixture with fibrinolytic action].
    SCARDIGLI G; GUIDI G; LOMBARDI V
    Minerva Med; 1961 Feb; 52():416-21. PubMed ID: 13747075
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymes and blood clotting. I. Trypsin as an accessory factor.
    FERGUSON JH; WILSON EG; IATRIDIS SG; RIERSON HA; JOHNSTON BR
    J Clin Invest; 1960 Dec; 39(12):1942-52. PubMed ID: 13698885
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the biological mechanism of the arterial hypotensive effects of a trypsin-heparin complex].
    SICUTERI F; MICHELACCI S; FRANCHI G; PERITI P
    Boll Soc Ital Biol Sper; 1962 Jul; 38():667-9. PubMed ID: 13912517
    [No Abstract]   [Full Text] [Related]  

  • 4. [Coagulation time in subcutaneous heparin treatment].
    von AHN
    Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the mechanism of heparin action on blood clotting and fibrinolysis].
    NIEWIAROWSKI S; WEGRZYNOWICZ Z
    Pol Tyg Lek; 1961 Jun; 16():901-5. PubMed ID: 13729010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on the mechanism of action of pcmaccelerin (factor V, labile factor). III. Inhibition of proaccelerin by heparin].
    GOBBI F; ASCARI E; BARBIERI U
    Prog Med (Napoli); 1961 Nov; 17():767-76. PubMed ID: 13899354
    [No Abstract]   [Full Text] [Related]  

  • 7. [The modification of the effect of trypsin on blood coagulation by natural and synthetic trypsin and thrombin inhibitors].
    Landman H; Markwardt F; Perlewitz J
    Thromb Diath Haemorrh; 1969 Dec; 22(3):552-68. PubMed ID: 5382290
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental cholesterin atherosclerosis in the rabbit: action of a duodenal heparinoid. III. Modifications in the factors of hemocoagulation, plasmin and plasminogen, and in the thromboplastin and fibrinolytic activity of the aortic wall].
    SOARDI F; NICROSINI F; DEL FAVERO A; PASOTTI C
    Farmaco Prat; 1961 Nov; 16():560-8. PubMed ID: 14039393
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of heparin on the bleeding time.
    HJORT PF; BORCHGREVINK CF; IVERSON OH; STORMORKEN H
    Thromb Diath Haemorrh; 1960 Jun; 4():389-99. PubMed ID: 14402076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heparin-trypsin complex and its effect on blood fibrinolytic properties in vitro and in vivo].
    Kudriashov BA; Klishevskaia TM; Bazaz'ian GG; Poliakova LA
    Vopr Med Khim; 1965; 11(3):45-52. PubMed ID: 5867957
    [No Abstract]   [Full Text] [Related]  

  • 11. [On blood hypercoagulability following the anticoagulant effect of heparin].
    BOCCARDI V; DERIU L
    Prog Med (Napoli); 1961 Sep; 17():607-14. PubMed ID: 13870323
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effect of heparin on factor V and factor VII complex in the human circulation].
    HENGSTMANN H; BECKER M
    Dtsch Arch Klin Med; 1962; 207():637-51. PubMed ID: 13906442
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin.
    BORCHGREVINK CF
    Acta Med Scand; 1961 Sep; 170():365-73. PubMed ID: 13871206
    [No Abstract]   [Full Text] [Related]  

  • 15. [The test of heparin tolerance "in vitro"].
    FORTEZA BOVER G; PERIS MORA R; TORMO ALFONSO V; ALGARRA VIDAL F
    Rev Clin Esp; 1960 Oct; 79():38-44. PubMed ID: 13700898
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of trypsin inhibitors on blood coagulation].
    BENZER H; BLUMEL G; PIZA F
    Wien Med Wochenschr; 1960 Jul; 110():609-12. PubMed ID: 13799068
    [No Abstract]   [Full Text] [Related]  

  • 17. Behaviour of the antithrombin time after extracorporeal circulation of blood.
    THIES HA
    Thromb Diath Haemorrh; 1960 Jun; 4():400-9. PubMed ID: 13837841
    [No Abstract]   [Full Text] [Related]  

  • 18. [The in-vitro heparin tolerance test in practice. II. The control of anticoagulant therapy].
    DALLA VOLTA S; FUSARO A
    Prog Med (Napoli); 1961 Apr; 17():223-30. PubMed ID: 13719441
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of lipoprotein lipase and clotting activity in lymph and plasma after heparin.
    CONNOR WE
    Proc Soc Exp Biol Med; 1961 Feb; 106():378-80. PubMed ID: 13695090
    [No Abstract]   [Full Text] [Related]  

  • 20. [The action of a substance with fibrinolytic activity in the prevention and treatment of postoperative peritoneal adhesions].
    Aulisa B; Gazzaniga M; Beretta T
    Minerva Chir; 1966 Feb; 21(4):133-8. PubMed ID: 5931214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.